Clinical Trials in Philadelphia

Showing 5781-5800 of 20,904 trials

Ibrutinib for Patients With Follicular Lymphoma Without Complete Response to Initial Chemoimmunotherapy

NCT02966730

The purpose of this study is to find out how successful ibrutinib is at putting follicular lymphoma into full remission. In this study, remission will be determined by achieving a normal PET scan after treatment. A PET scan is an imaging test that looks for active lymphoma. People who don't have a complete remission on PET after their first treatment are at high risk for having their lymphoma return. This study will investigate if ibrutinib will help participants achieve a complete remission without giving additional chemotherapy. The study will also investigate any possible side effects of the study drug ibrutinib.

Follicular LymphomaFollicular Lymphoma, Grade 1Follicular Lymphoma, Grade 2+1 more

Memorial Sloan Kettering Cancer Center2 participantsStarted Nov 2016

Basking Ridge, New Jersey, United States • Middletown, New Jersey, United States • Montvale, New Jersey, United States +6 more locations

Active Not Recruiting< 1 mile

Pediatric ACL: Understanding Treatment Options

NCT02772770

Pediatric ACL: Understanding Treatment Outcomes (PLUTO) is a multi-center, prospective cohort study. Specific aims of PLUTO are to evaluate the safety and comparative effectiveness of non-operative treatment, as well as four operative treatments including (1) transphyseal ACL reconstruction (2) partial transphyseal ACL reconstruction, (3) physeal-sparing epiphyseal ACL reconstruction using the Anderson technique, and (4) physeal-sparing ACL reconstruction using the Micheli/Kocher technique in prepubescent and pubescent skeletally immature patients.

Anterior Cruciate Ligament Reconstruction

Boston Children's Hospital765 participantsStarted Sep 2016

Palo Alto, California, United States • San Diego, California, United States • Atlanta, Georgia, United States +7 more locations

Ibrutinib for Patients With Follicular Lymphoma Without Complete Response to Initial Chemoimmunotherapy

Pediatric ACL: Understanding Treatment Options

Find Trials by Condition in Philadelphia

STEM-Parkinson's Disease

Adalimumab in JIA-associated Uveitis Stopping Trial

A Study of SEA-CD40 Given With Other Drugs in Cancers

Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia

Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation

Vector Efficacy Cross-Over Pilot Study

Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors

A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma

Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder

A Phase 2 Biomarker - Enriched Study of TH-302 in Subjects With Advanced Melanoma

Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.

Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease

Peru Decentralized HIV Care

Impairments That Affect Correct Inhaler Use in COPD

SARS-CoV-2 and Influenza A/B in Point-of-Care and Non-Laboratory Settings

Changing the Paradigm of In-Hospital Cardiopulmonary Resuscitation